Arvinas Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Arvinas Inc.
- Former names
- Arvinas Holding Company, LLC
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- New Haven
- Headquarters state / province
- Connecticut
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ARVN
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001655759
- EIN
- 47-2566120
Board of directors
-
Alsup Laurie Smaldone · DirectorSince 2023
-
Briggs Morrison · DirectorSince 2023
-
Edward Moore Kennedy Jr. · DirectorSince 2023
-
Everett Cunningham · DirectorSince 2023
-
John D. Young · DirectorSince 2023
-
John G. Houston · Director · President and CEOSince 2023
-
Leslie Norwalk V · DirectorSince 2023
-
Linda Bain · DirectorSince 2023
-
Randy Teel · Director · President and CEOSince 2026
-
Sunil Agarwal · DirectorSince 2023
-
Wendy L. Dixon · DirectorSince 2023
Chief executives
Randy Teel
· President and CEO
Since February 2026
John G. Houston
· President and CEO
Until February 2026
· Former
Director election results
Annual meeting of June 24, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
75.8%
-
99.1%
Board connections
9 of this board's directors also sit on 15 other boards.
- via Linda Bain
- via Wendy L. Dixon
- via Alsup Laurie Smaldone
- via Briggs Morrison
- via Leslie Norwalk V
- via Leslie Norwalk V
- via Linda Bain
- via Edward Moore Kennedy Jr.
- via John D. Young
- via Leslie Norwalk V
- via John G. Houston
- via Everett Cunningham
- via Briggs Morrison
- via Briggs Morrison
- via Wendy L. Dixon
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $268,000
- 1 purchase by 1 insider
- Sold, last 12 months
- $1,421,299
- 23 sales by 6 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 24, 2026 | Alsup Laurie Smaldone Director | Grant or award | +15,527 | — | — |
| Jun 24, 2026 | Leslie Norwalk V Director | Grant or award | +15,527 | — | — |
| Jun 24, 2026 | Briggs Morrison Director | Grant or award | +15,527 | — | — |
| Jun 24, 2026 | Edward Moore Kennedy Jr. Director | Grant or award | +15,527 | — | — |
| Jun 24, 2026 | Everett Cunningham Director | Grant or award | +15,527 | — | — |
| Jun 24, 2026 | Linda Bain Director | Grant or award | +15,527 | — | — |
| Jun 24, 2026 | Andrew Saik Officer (Chief Financial Officer) | Open-market sale | −5,696 | $8.16 | $46,479 |
| Jun 17, 2026 | Cacace Angela M Officer (Chief Scientific Officer) | Open-market sale | −2,576 | $7.60 | $19,578 |
| May 21, 2026 | Randy Teel Director, Officer (President and CEO) | Open-market sale | −2,209 | $9.04 | $19,969 |
| May 11, 2026 | Andrew Saik Officer (Chief Financial Officer) | Open-market sale | −11,139 | $9.94 | $110,722 |
| May 11, 2026 | Loomis David K Officer (VP, Chief Accounting Officer) | Open-market sale | −1,919 | $9.94 | $19,075 |
| May 11, 2026 | Cacace Angela M Officer (Chief Scientific Officer) | Open-market sale | −9,657 | $9.94 | $95,991 |
| May 11, 2026 | Berkowitz Noah Officer (Chief Medical Officer) | Open-market sale | −11,108 | $9.94 | $110,414 |
| May 11, 2026 | Randy Teel Director, Officer (President and CEO) | Open-market sale | −9,657 | $9.94 | $95,991 |
| Mar 18, 2026 | Berkowitz Noah Officer (Chief Medical Officer) | Open-market sale | −6,435 | $11.10 | $71,429 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.